Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05402384 · ClinicalTrials.gov registry record · Phase 2
AVTX-801 D-galactose Supplementation in SLC35A2-CDG
A Phase 2 study, sponsored by Eva Morava-Kozicz.
- Not yet
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT05402384: Clinical Trial Phase 2 study, sponsored by Eva Morava-Kozicz.
NCT05402384 is a Phase 2 study that has not yet begun recruiting, run by Eva Morava-Kozicz. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05402384, a Phase 2 study, has not yet begun recruiting, sponsored by Eva Morava-Kozicz.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a multicenter, randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy and safety of AVTX-801 in subjects with SLC35A2-CDG
Primary Outcome
Seizure burden assessed by change from baseline in 28-day major motor seizure frequency
Interventions
- DRUG Placebo
- DRUG AVTX-801
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2027-01 |
| Est. Completion | 2028-03 |
| Phase | Phase 2 |
What is known before NCT05402384 opens enrollment
NCT05402384 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05402384 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05402384 about?
NCT05402384 is a clinical study titled "AVTX-801 D-galactose Supplementation in SLC35A2-CDG". This is a multicenter, randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy and safety of AVTX-801 in subjects with SLC35A2-CDG
What is the current status of trial NCT05402384?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2027-01. Estimated completion is 2028-03.
What interventions are being tested in trial NCT05402384?
The interventions under investigation include: Placebo (DRUG), AVTX-801 (DRUG).
Who is sponsoring clinical trial NCT05402384?
This trial is sponsored by Eva Morava-Kozicz, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05402384's enrollment target sits among peer trials
10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia